Presentation is loading. Please wait.

Presentation is loading. Please wait.

Agent-based methods for translational cancer multilevel modelling Sylvia Nagl PhD Cancer Systems Science & Biomedical Informatics UCL Cancer Institute.

Similar presentations


Presentation on theme: "Agent-based methods for translational cancer multilevel modelling Sylvia Nagl PhD Cancer Systems Science & Biomedical Informatics UCL Cancer Institute."— Presentation transcript:

1 Agent-based methods for translational cancer multilevel modelling Sylvia Nagl PhD Cancer Systems Science & Biomedical Informatics UCL Cancer Institute London

2 Main points of the talk Potential of agent-based modelling Systems biology perspective on large cell network simulation A new synergy between modelling and wet biology

3 Hanahan and Weinberg (2000) Cell 100:57-70 The hallmarks of cancer

4 Systems biology and medicine Diseases are abnormal perturbations of biological networks - through defects in molecular mechanisms or environmental stimuli Therapies are the interventions needed to restore networks to their normal states

5 Butcher et al. (2004) Nature Biotechnology 22:1253 Modelling challenge: genome to phenotype extended genotype elementary phenotype

6 Systems biology and medicine Fundamental question of where function lies within a cell –distributed (networks of interacting molecules) –hierarchical network motifs and modules complex network connecting modules A globalist view of the dynamics of (large) cell networks is therefore needed cell and tissue levels cell networks molecular interactions (molecular dynamics) E-science }

7 Systems biology and cancer Given the many components of functional modules, there are different paths to disease-inducing systems failure A multitude of ways to ‘solve’ the problems of achieving a survival advantage in cancer cells Each patient’s cancer cells evolve through an independent set of genomic lesions and selective environments - a fundamental reason for differences in survival and treatment response

8 Likelihood of cancer cell death in response to DNA damaging drugs and radiotherapy DNA damage response network Supporting treatment optimisation in the individual patient

9 Agent-based modelling Agent based model Simulation A1A2 A1 Ai A2 One-to-one mapping of cell components to computational agents Agents at multiple levels: Protein, network motif, module (organelle, cell …) Interaction rules Translates wealth of molecular knowledge into component-based models Patient-specific molecular data ?

10 TF1 S1 S2 SN TF2 TFm Signal-genetic network Environment Transcription factors Genes DNA damage Changes in genome activation

11 TF1 S1 S2 SN TF2 TFm Signal-genetic network Environment Transcription factors Genes Agent-based modelling: ‘Agent’ (protein, motif, module) => behaviour rules Kinetics/step function/Boolean variables scale up to large networks

12 Challenge: Emergence Coherent behaviour of cells emerges from interactions between a large number of system components – proliferation, cell death, resistance to drugs ‘Computational’ definition of emergence: Unspecified properties and behaviours arise from interaction between agents rather than as a consequence of a single agent’s actions Methods for analysis needed e.g. for therapy target discovery

13 Detecting event patterns in time A simple event is a state transition due to a rule execution A complex event is made up of a set of interrelated simple events Classification of complex events in a simulation allows one to discover associations between processes at different levels Published formalism available at www.cs.ucl.ac.uk/staff/C.Chen/research.html

14 Linking network simulations to integrated cell behaviour requires knowledge external to the simulation, the question of ‘biological meaning’ Challenge: ‘the gap’

15 A new synergy Data generation is still largely motivated by a non-systems-based research paradigm Systems biologists then seek to use these data to build and validate models of systems – with difficulties We need to rethink the relationship between experiment and modelling –both need to proceed within a complex systems framework –new kinds of experiments needed to investigate multi-level relationships in the wet system e. g., global signal network states need to be matched to cell- level phenotypic measurements over time and under a range of conditions E-science systems modelling and experiment need to complement and synergise

16 Acknowledgements Nuno Rocha Nene (CoMPLEX PhD programme) Chih-Chun Chen (interdisciplinary EPSRC DTA awards) CR UK, Department of Health Published formalism available at www.cs.ucl.ac.uk/staff/C.Chen/research.html www.cs.ucl.ac.uk/staff/C.Chen/research.html Decision support tool for ABM techniques www.abmsystemsbiology.info www.abmsystemsbiology.info My email: s.nagl@ucl.ac.uk


Download ppt "Agent-based methods for translational cancer multilevel modelling Sylvia Nagl PhD Cancer Systems Science & Biomedical Informatics UCL Cancer Institute."

Similar presentations


Ads by Google